Tower Research Capital (TRC)’s NeuroSense Therapeutics NRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,794	Closed	-$33K	–	6346
2022 Q2	$33K	Buy	9,794 +9,494	+3,165%	+$32K	﹤0.01%	3277
2022 Q1	$1K	Sell	300 -1,023	-77%	-$3.41K	﹤0.01%	5830
2021 Q4	$3K	Buy	+1,323	New	+$3K	﹤0.01%	5471